WHO guidance on GLP-1 medicines

Another study looking into the wide-reaching benefits of the shingles vaccine suggests it can stave off mild cognitive impairment and even slow down the course of dementia. 

Also, the World Health Organization (WHO) releases its guidelines for the use of GLP-1s in overweight and obesity. 

And updated advice for prescribing these medications when it comes to birth control and mental health. 

References

• The effect of shingles vaccination at different stages of the dementia disease course 
• WHO issues global guideline on the use of GLP-1 medicines in treating obesity 
• Product warnings updated for GLP-1 RA class - TGA